Scholarlink

Background <p>Antibiotics are crucial for treating infectious diseases, but their appropriate use is essential to minimize adverse reactions and resistance. This study evaluated the effectiveness of protocol-based pharmacotherapy management (PBPM) based on renal function in adjusting antibiotic dosage and implementing an intravenous-to-oral switch in older patients at high risk of drug-related adverse events. The study compared antibiotic treatment outcomes before and after PBPM implementation at Kyoto University Hospital.</p> Methods <p>This before-and-after study included patients aged ≥ 65 years diagnosed with community-acquired pneumonia or uncomplicated pyelonephritis at Kyoto University Hospital. The control group (January to December 2021) received conventional antibiotic treatment, whereas the PBPM group (June 2022 to May 2023) received treatment based on a protocol developed by pharmacists, emergency physicians, and infectious disease specialists. Primary and secondary outcomes included antibiotic administration duration, clinical response, adverse reactions, and costs.</p> Results <p>The study included 78 patients (40 control, 38 PBPM). The PBPM group showed a significantly shorter total antibiotic treatment duration (9.6 ± 4.4 vs. 7.5 ± 2.4 days, <i>P</i> &lt; 0.05) and intravenous administration duration (7.1 ± 2.8 vs. 5.6 ± 2.2 days, <i>P</i> &lt; 0.01) compared with the control group. The PBPM group also demonstrated lower clinical treatment failure rates and reduced incidences of acute kidney injury and alanine aminotransferase elevation. Antibiotic costs per patient were 13% lower in the PBPM group. There were no significant differences in early clinical response, readmission rates, or mortality between groups.</p> Conclusions <p>PBPM, conducted collaboratively by pharmacists and physicians, effectively optimized antibiotic use, reduced adverse event risks, shortened treatment duration, and lowered healthcare costs without compromising clinical outcomes. These findings support PBPM implementation to improve antibiotic stewardship in older patients with common infections.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy of protocol-based pharmacotherapy management in switching of antibiotic administration routes and dose adjustment based on renal function: a before-after study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月24日

查看全文
  • Yuki Sato,
  • Yudai Takatani,
  • Shunsaku Nakagawa,
  • Yoshiki Katada,
  • Yasuhiro Tsuchido,
  • Mitsuhiro Sugimoto,
  • Masanori Kimata,
  • Mamiko Saigo,
  • Masahiro Tsuda,
  • Shigeru Ohtsuru,
  • Tomohiro Terada

摘要

Background

Antibiotics are crucial for treating infectious diseases, but their appropriate use is essential to minimize adverse reactions and resistance. This study evaluated the effectiveness of protocol-based pharmacotherapy management (PBPM) based on renal function in adjusting antibiotic dosage and implementing an intravenous-to-oral switch in older patients at high risk of drug-related adverse events. The study compared antibiotic treatment outcomes before and after PBPM implementation at Kyoto University Hospital.

Methods

This before-and-after study included patients aged ≥ 65 years diagnosed with community-acquired pneumonia or uncomplicated pyelonephritis at Kyoto University Hospital. The control group (January to December 2021) received conventional antibiotic treatment, whereas the PBPM group (June 2022 to May 2023) received treatment based on a protocol developed by pharmacists, emergency physicians, and infectious disease specialists. Primary and secondary outcomes included antibiotic administration duration, clinical response, adverse reactions, and costs.

Results

The study included 78 patients (40 control, 38 PBPM). The PBPM group showed a significantly shorter total antibiotic treatment duration (9.6 ± 4.4 vs. 7.5 ± 2.4 days, P < 0.05) and intravenous administration duration (7.1 ± 2.8 vs. 5.6 ± 2.2 days, P < 0.01) compared with the control group. The PBPM group also demonstrated lower clinical treatment failure rates and reduced incidences of acute kidney injury and alanine aminotransferase elevation. Antibiotic costs per patient were 13% lower in the PBPM group. There were no significant differences in early clinical response, readmission rates, or mortality between groups.

Conclusions

PBPM, conducted collaboratively by pharmacists and physicians, effectively optimized antibiotic use, reduced adverse event risks, shortened treatment duration, and lowered healthcare costs without compromising clinical outcomes. These findings support PBPM implementation to improve antibiotic stewardship in older patients with common infections.

Clinical trial number

Not applicable.